UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 315

Sortiert nach

The NTCP‐inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics

Clinical pharmacology and therapeutics, 2018-02, Vol.103 (2), p.341-348

2018

Link zum Volltext

Verfügbarkeit prüfen

Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation

Cell death & disease, 2015-02, Vol.6 (2), p.e1657-e1657

2015

Link zum Volltext

Verfügbarkeit prüfen

Determining the Time Course of CYP3A Inhibition by Potent Reversible and Irreversible CYP3A Inhibitors Using A Limited Sampling Strategy

Clinical pharmacology and therapeutics, 2011-11, Vol.90 (5), p.666-673

2011

Link zum Volltext

Verfügbarkeit prüfen

Expanding the chemical scope of RNA:methyltransferases to site-specific alkynylation of RNA for click labeling

Nucleic acids research, 2011-03, Vol.39 (5), p.1943

2011

Link zum Volltext

Verfügbarkeit prüfen

Steady-state pharmacokinetics and metabolism of voriconazole in patients

Journal of antimicrobial chemotherapy, 2013-11, Vol.68 (11), p.2592-2599

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Efavirenz Autoinduction and Its Effect on Plasma Exposure in HIV Patients

Clinical pharmacology and therapeutics, 2010-11, Vol.88 (5), p.676-684

2010

Link zum Volltext

Verfügbarkeit prüfen

Potential contribution of computer-aided detection to the sensitivity of screening mammography

Radiology, 2000-05, Vol.215 (2), p.554

2000

Link zum Volltext

Verfügbarkeit prüfen

High plasma efavirenz level and CYP2B66 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study

The pharmacogenomics journal, 2012-12, Vol.12 (6), p.499-506

2012

Link zum Volltext

Verfügbarkeit prüfen

Higher chlorzoxazone clearance in obese children compared with nonobese peers

British journal of clinical pharmacology, 2018-08, Vol.84 (8), p.1738-1747

2018

Link zum Volltext

Verfügbarkeit prüfen

Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients

Journal of antimicrobial chemotherapy, 2011-10, Vol.66 (10), p.2350-2361

2011

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients

The pharmacogenomics journal, 2013-12, Vol.13 (6), p.484-489

2013

Link zum Volltext

Verfügbarkeit prüfen

Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir

Clinical pharmacology and therapeutics, 2006-08, Vol.80 (2), p.126-135

2006

Link zum Volltext

Verfügbarkeit prüfen

No alteration of Cyp3A4 activity after major hepatectomy in the early postoperative period – A prospective before-after study

International journal of surgery (London, England), 2020-07, Vol.79, p.131-135

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of Rifampicin and CYP2B6 Genotype on Long‐Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without Tuberculosis

Clinical pharmacology and therapeutics, 2011-09, Vol.90 (3), p.406-413

2011

Link zum Volltext

Verfügbarkeit prüfen

Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics

Clinical pharmacology and therapeutics, 2005-07, Vol.78 (1), p.25-33

2005

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4β-hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment

Journal of antimicrobial chemotherapy, 2014-12, Vol.69 (12), p.3311-3319

2014

Link zum Volltext

Verfügbarkeit prüfen

Invasive lobular carcinoma of the breast: mammographic characteristics and computer-aided detection

Radiology, 2002-10, Vol.225 (1), p.182

2002

Link zum Volltext

Verfügbarkeit prüfen

CYP2C9 Polymorphism is not a Major Determinant of Bosentan Exposure in Healthy Volunteers

Clinical pharmacology and therapeutics, 2014-03, Vol.95 (3), p.250-251

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of Simultaneous Induction and Inhibition of CYP3A by St John's Wort and Ritonavir on CYP3A Activity

Clinical pharmacology and therapeutics, 2010-02, Vol.87 (2), p.191-196

2010

Link zum Volltext

Verfügbarkeit prüfen

CYP3A5 Genotype has an Impact on the Metabolism of the HIV Protease Inhibitor Saquinavir

Clinical pharmacology and therapeutics, 2007-05, Vol.81 (5), p.708-712

2007

Link zum Volltext

Verfügbarkeit prüfen

Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin–clarithromycin interaction

British journal of clinical pharmacology, 2003-07, Vol.56 (1), p.32-38

2003

Link zum Volltext

Verfügbarkeit prüfen

Voriconazole-Induced QT Interval Prolongation and Ventricular Tachycardia: A Non—Concentration-Dependent Adverse Effect

Clinical infectious diseases, 2004-09, Vol.39 (6), p.e49-e52

2004

Link zum Volltext

Verfügbarkeit prüfen

Combination of the Hepatitis B/D Entry Inhibitor Myrcludex B and Tenofovir: Assessment of the Effect on Plasma Bile Acid Profiles and Tenofovir Pharmacokinetics

Journal of hepatology, 2016, Vol.64 (2), p.S164-S164

2016

Link zum Volltext

Verfügbarkeit prüfen

Management of chronic pain using extended release tilidine : Quality of life and implication of comedication on tilidine metabolism

Schmerz (Berlin, Germany), 2017-10, Vol.31 (5), p.516-523

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4 -hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment

Journal of antimicrobial chemotherapy, 2014-12, Vol.69 (12), p.3311-3319

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 315

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(271)
Mit Volltextzugriff
(187)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(224)
Life Sciences & Biomedicine
(216)
Humans
(210)
Radiology, Nuclear Medicine & Medical Imaging
(115)
Female
(102)
Biological And Medical Sciences
(88)
Medical Sciences
(83)
Male
(78)
Adult
(72)
Middle Aged
(72)
Aged
(50)
Cholelithiasis - Therapy
(46)
Pharmacology & Pharmacy
(39)
Radiography
(28)
Gastroenterology. Liver. Pancreas. Abdomen
(26)
Pharmacology. Drug Treatments
(26)
Ultrasonography
(26)
Cholangiography
(24)
Lithotripsy
(23)
Aged, 80 And Over
(22)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The NTCP‐inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics

Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation

Determining the Time Course of CYP3A Inhibition by Potent Reversible and Irreversible CYP3A Inhibitors Using A Limited Sampling Strategy

Expanding the chemical scope of RNA:methyltransferases to site-specific alkynylation of RNA for click labeling

Steady-state pharmacokinetics and metabolism of voriconazole in patients

Long-Term Efavirenz Autoinduction and Its Effect on Plasma Exposure in HIV Patients

Potential contribution of computer-aided detection to the sensitivity of screening mammography

High plasma efavirenz level and CYP2B66 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study

Higher chlorzoxazone clearance in obese children compared with nonobese peers

Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients

Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients

Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir

No alteration of Cyp3A4 activity after major hepatectomy in the early postoperative period – A prospective before-after study

Effect of Rifampicin and CYP2B6 Genotype on Long‐Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without Tuberculosis

Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics

Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4β-hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment

Invasive lobular carcinoma of the breast: mammographic characteristics and computer-aided detection

CYP2C9 Polymorphism is not a Major Determinant of Bosentan Exposure in Healthy Volunteers

Effect of Simultaneous Induction and Inhibition of CYP3A by St John's Wort and Ritonavir on CYP3A Activity

CYP3A5 Genotype has an Impact on the Metabolism of the HIV Protease Inhibitor Saquinavir

Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin–clarithromycin interaction

Voriconazole-Induced QT Interval Prolongation and Ventricular Tachycardia: A Non—Concentration-Dependent Adverse Effect

Combination of the Hepatitis B/D Entry Inhibitor Myrcludex B and Tenofovir: Assessment of the Effect on Plasma Bile Acid Profiles and Tenofovir Pharmacokinetics

Management of chronic pain using extended release tilidine : Quality of life and implication of comedication on tilidine metabolism

Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4 -hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment

Suchergebnisse filtern